| Phuong Dieu Nguyen, PHARM D | |
|
3500 Coffee Rd, Modesto, CA 95355-1305 | |
| (209) 341-0814 | |
| (209) 341-0849 |
| Full Name | Phuong Dieu Nguyen |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3500 Coffee Rd, Modesto, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861779316 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 48747 (California) | Primary |
| 183500000X | Pharmacist | 13425 (Nevada) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Phuong Dieu Nguyen, PHARM D 3604 Kee Ln, Modesto, CA 95355-8662 Ph: (209) 380-0338 | Phuong Dieu Nguyen, PHARM D 3500 Coffee Rd, Modesto, CA 95355-1305 Ph: (209) 341-0814 |
News Archive
Liver metastases predicts shorter overall survival in men with metastatic castration-refractory prostate cancer (mCRPC), according to data being presented at the 2012 American Society of Clinical Oncology Annual Meeting in Chicago.
The Endocrine Society's new scientific statement published online today represents the first comprehensive evaluation of both the basic and clinical evidence related to the non-skeletal effects of vitamin D. The statement addresses current research regarding the associations of vitamin D with immune function, hypertension, stroke, skin conditions and maternal/fetal health.
New research by scientists at the University of Medicine and Dentistry of New Jersey-School of Osteopathic Medicine (UMDNJ-SOM) demonstrates how dying or damaged brain cells release debris into the bloodstream and give rise to specific autoantibodies that appear to be reliable biomarkers for early diagnosis of Alzheimer's and other neurodegenerative diseases.
Biotech company Pharming Group NV has announced that the US Food and Drug Administration (FDA) has authorized a clinical study with recombinant human C1 inhibitor (rhC1INH) for the treatment of antibody-mediated rejection (AMR) in kidney transplantation. Dr. Hans Sollinger of the University of Wisconsin, Madison will conduct the clinical trial with rhC1INH under an Investigator IND from the FDA.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today reported financial results for the first quarter of 2010.
› Verified 6 days ago
Dr. Sujeev Vhan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3405 Mchenry Ave, T-0273, Modesto, CA 95350 Phone: 209-523-6210 | |
Cindie Masui, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1032 Oakdale Rd, Modesto, CA 95355 Phone: 209-577-6060 | |
Mrs. Truc Thanh Vo, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1101 Mchenry Ave, Modesto, CA 95350 Phone: 209-577-8695 | |
Grace Cho, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2900 Standiford Ave, Modesto, CA 95350 Phone: 209-522-1093 | |
Kenia Yulissa Medina Moreno, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1441 Florida Ave, Modesto, CA 95350 Phone: 209-576-3622 | |
Dr. Stephanie Tovar, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1700 Coffee Rd, Modesto, CA 95355 Phone: 209-526-4500 | |
Ashley Avila, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3801 Pelandale Ave, Modesto, CA 95356 Phone: 209-342-4902 |